Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline

Publish date: July 27, 2018

 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Infectious Disease
Analysis finds inconsistent uptake of meningococcal B vaccines
MDedge Infectious Disease
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Infectious Disease
Myelin antibody predicts ADEM relapse
MDedge Infectious Disease
High-dose opioid prescribing linked to heroin use risk among U.S. veterans
MDedge Infectious Disease
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Infectious Disease
Assessing adverse events tied to outpatient opioid use in children
MDedge Infectious Disease
Is fibromyalgia one disorder – or two?
MDedge Infectious Disease
Is fish oil’s heart benefit a fish tale?
MDedge Infectious Disease
Blood pressure meds cut cognitive impairment risk
MDedge Infectious Disease